Early Phase 1 Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old
- People who have a confirmed diagnosis of multiple sclerosis (MS)
- People who are able to look at a computer screen and follow instructions in English, assessed by a short memory and thinking test where a score above 24 out of 30 is required
- People who are right-handed, as measured by a standard handedness questionnaire
- People who report having normal vision, or vision that is corrected to normal (for example, with glasses or contact lenses)
Who may not be able to join:
- People with a psychiatric condition that requires medication, as those medications may affect brain activity results
- People with a neurological condition other than MS that could affect thinking, balance, or physical health — such as a brain injury or stroke
- People with a bone, joint, or muscle and nerve disorder that may affect balance or the ability to move around
- People who are currently taking part in another thinking (cognitive) or physical training program during the study period
- People who have had a relapse (new or returning MS symptoms) or have received steroid treatment in the 30 days before joining the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Soha Saleh, PhD, Rutgers University
Phone: 9739720472
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
walking speed; Dynamic Gait Index (DGI); Resting-state brain connectivity; brain-muscle coherence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.